Synthetic Peptide
DcR1 Synthetic Peptide, PEP-0057, from Invitrogen.
TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175769 |
| Réf. fabricant | 15206289 |
| Gene ID (Entrez) | 8794 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | O14798 |
| Nom usuel | Human CD263 (TRAIL-R3) |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TNFRSF10C |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
